SHP-2

SHP-2 Overview

English NameSrc homology phosphotyrosyl phosphatase 2Approved Drugs0
Drugs in Clinical Trials21Target SynonymProtein Tyrosine Phosphatase Non-Receptor Type 11,SHP-2,PTP2C,Protein-tyrosine phosphatase 2C,PTP-2C,PTP-1D,SH-PTP3,PTPN11,Protein-Tyrosine Phosphatase 1D,SH-PTP2,EC:3.1.3.48,Noonan Syndrome 1,EC 3.1.3.48,METCDS,SHPTP2,BPTP3,JMML,SHP2,CFC,NS1,Protein Tyrosine Phosphatase, Non-Receptor Type 11,Tyrosine-Protein Phosphatase Non-Receptor Type 11
Highest Development StagePhase 3 Clinical
English NameSrc homology phosphotyrosyl phosphatase 2
Target SynonymProtein Tyrosine Phosphatase Non-Receptor Type 11,SHP-2,PTP2C,Protein-tyrosine phosphatase 2C,PTP-2C,PTP-1D,SH-PTP3,PTPN11,Protein-Tyrosine Phosphatase 1D,SH-PTP2,EC:3.1.3.48,Noonan Syndrome 1,EC 3.1.3.48,METCDS,SHPTP2,BPTP3,JMML,SHP2,CFC,NS1,Protein Tyrosine Phosphatase, Non-Receptor Type 11,Tyrosine-Protein Phosphatase Non-Receptor Type 11
Approved Drugs0
Drugs in Clinical Trials21
Highest Development StagePhase 3 Clinical

SHP-2 Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
SH2-H5248
Human
E. coli
Human SHP-2 Protein, His Tag
Total: 1
  • 1

SHP-2 Background

SHP-2, a cytoplasmic SH2 domain containing protein tyrosine phosphatase, is involved in the signaling pathways of a variety of growth factors and cytokines. SHP-2 takes key role in transducing signal relay from the cell surface to the nucleus, and is a important intracellular regulator in mediating cell proliferation and differentiation.

SHP-2 Synonyms

SHP-2

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
SitneprotafibJAB-3312; AST24082Phase 3 ClinicalJacobio Pharmaceuticals Co LtdBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
Details
JAB-3068JAB-3068Phase 2 ClinicalAbbvie Inc, Jacobio Pharmaceuticals Co LtdCarcinoma, Adenoid Cystic; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Head and Neck Neoplasms; Lymphoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
Details
VociprotafibRMC-4630; SAR-442720Phase 2 ClinicalRevolution Medicines Inc, SanofiCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
BatoprotafibTNO-155Phase 2 ClinicalNovartis Pharma AgCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Gastrointestinal Stromal Tumors; Hepatic Insufficiency; Lung Neoplasms; Melanoma; Neoplasm Metastasis; Neoplasms; Renal Insufficiency; Solid tumours; Squamous Cell Carcinoma of Head and Neck
Details
GH-21GH 21005; GH-21; HBI-2376Phase 2 ClinicalSuzhou Genhouse Bio Co LtdCarcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
BR-790BR-790Phase 2 ClinicalJiangxi Qingfeng Pharmaceutical Industry Co LtdCarcinoma, Non-Small-Cell Lung; Neoplasms; Solid tumours
Details
ERAS-601ERAS-601Phase 2 ClinicalNiKang Therapeutics IncChordoma; Leukemia, Myeloid, Acute; Solid tumours
Details
BBP-398IACS-15509; BBP-398; IACS-13909; BMS-986466Phase 2 ClinicalBridgebio Pharma Inc, The University Of Texas MD Anderson Cancer CenterCarcinoma, Non-Small-Cell Lung; Solid tumours
Details
MigoprotafibRLY-1971; GDC-1971; RO-7517834; RG-6433Phase 1 ClinicalRelay Therapeutics IncCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Solid tumours
Details
A-380A-380Phase 1 ClinicalKlus Pharma Inc, Shandong Kelun Phaemaceutical Co LtdNeoplasms
Details
KYHY-2303KYHY2303; KYHY-2303Phase 1 ClinicalJiangsu Kanion Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of SciencesHematologic Neoplasms
Details
RG-001RG001; RG-001Phase 1 ClinicalRudong Ringene Pharmaceuticals Co Ltd, Shanghai Lingji Biological Technology Co LtdNeoplasms
Details
HS-336HS336; HS-336Phase 1 ClinicalZhejiang Hisun Pharmaceutical Co LtdSolid tumours
Details
HMPL-415S1HMPL-415S1Phase 1 ClinicalSolid tumours
Details
PH-005PH005; PH-005Phase 1 ClinicalSuzhou Puhe Pharmaceutical Technology Co LtdSolid tumours
Details
BPI-442096Phase 1 ClinicalBetta Pharmaceuticals Co LtdCarcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
HS-10381HS-10381Phase 1 ClinicalJiangsu Hansoh Pharmaceutical Group Co LtdSolid tumours
Details
ET-0038ET-0038Phase 1 ClinicalEtern BioPharma (Shanghai) Co LtdSolid tumours
Details
PF-07284892ARRY-558; PF-07284892Phase 1 ClinicalPfizer IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Solid tumours
Details
ICP-189ICP-189Phase 1 ClinicalInnoCare Pharma LtdCarcinoma, Non-Small-Cell Lung; Solid tumours
Details
SH-3809SH3809Phase 1 ClinicalNanjing Sanhome Pharmaceutical Co Ltd Solid tumours
Details
  • Overview
  • Product List
  • Clinical Drug Information